z-logo
open-access-imgOpen Access
Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone
Author(s) -
O. Hamdine,
Marinus J.C. Eijkemans,
E. Lentjes,
Helen L. Torrance,
N.S. Macklon,
Bart C.J.M. Fauser,
Frank J. Broekmans
Publication year - 2014
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deu266
Subject(s) - anti müllerian hormone , medicine , hormone antagonist , antagonist , ovarian reserve , gynecology , ovulation induction , agonist , in vitro fertilisation , hormone , pregnancy , andrology , infertility , biology , ovulation , receptor , genetics
What is the clinical value of anti-Müllerian hormone (AMH) for the prediction of high or low ovarian response in controlled ovarian stimulation for IVF using GnRH antagonist treatment?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom